John Dinusson

President and Chief Operating Officer, Director

2024 - Current

EXtrance is a holistic solution designed to modernize how investments are managed. Powered by secure, next-generation technologies, this platform exposes actionable, data-based insights, streamlines workflows, automates processes, and facilitates transactions at the asset and portfolio level.

Executive Vice President

2023 - 2024

Providing the best user experience for both physicians and patients with our telehealth platform and innovative non-narcotic devices.

President & CEO, Director

2022 - 2023

Eva Medtec is the creator of Neuroglide, a system of automated therapy devices which provide effective, convenient, and sustainable medical devices for pain and circulation. Neuroglide emulates manual lymphatic drainage (facilitation).

Interim Chief Executive Officer and President, Director

2022 - 2022

SubioMed a pioneer in the invention and development of Suspension Biomechanics™ technology which addresses critical elements of gait, balance and ground reduction force.

Founder, CEO & President, Director

2007 - 2021

OrthoCor Medical develops and delivers drug-free, non-invasive, and mobile medical technology, using pulsed electromagnetic field (PEMF) technology to help patients manage pain, regain physical function, and contribute to an active lifestyle. OrthoCor Medical was acquired in 2016 and continued to run as an independent company focusing on the orthopedic and pain management markets. EXECUTIVE LEADERSHIP | STRATEGIC PLANNING | FUNDRAISING • Develop, executed, monitored, and adjusted ongoing strategic growth plans. • Worked with the Mayo Clinic and University of Minnesota to develop the OrthoCor Medical technology. • Raised $6.5M in equity financing from 80 angel investors. • Grew the company from inception to 14 high-performing team members and leaders the organization. • Recruited, hired, developed, and retained independent sales force and direct sales management team. • Grew revenue at an exceptional rate with extremely high-profit margins. • Increased year over years sales revenue. o 2016 sales revenue growth over 2015 of 500% o 2017 sales revenue growth over 2016 of 70% o 2018 sales revenue growth over 2017 of 155.26% o 2019 sales revenue growth over 2018 of 192.75% o 2020 sales revenue growth over 2019 (COVID-19) of 91.54% • Worked with investment bankers in the sale of the company. • Served on the Board of Directors for OrthoCor Medical and Caerus Corp. PRODUCT INNOVATION | COMMERCIALIZATION • Hired and worked directly with an FDA consultant to obtain four FDA clearances. • Led/participated in three FDA audits without any issues or warnings. • Commercialized nine FDA-cleared Class III orthopedic devices. • Received Medicare HCPCS codes from PDAC. • Developed company sales model including coverage and payment in three separate markets including Workers Comp, VA and Personal Injury markets. • Worked with Q&A, R&D, and manufacturing to launch nine next-generation products.

Adjunct Faculty - Graduate studies in Finance, Valuation & Entrepreneurship, School of Engineering

2016 - 2020

Financial Advisor

2016 - 2020

Vugo is a software only mobility media company that places targeted ads and media in for-hire vehicles like rideshares and taxicabs. Vugo helps advertisers reach a captive high-quality audience.

Chairman of the Board

2016 - 2018

Early stage medical device company that is bringing peace of mind to life for severe allergy sufferers

Vice President, Private Banking

2007 - 2008

• Managed portfolio for a $1.1B community bank in the Private Banking Group. • Focused on high-net-worth individuals, alternative energy, non-profits, and commercial businesses. • Originated loans and sold corporate and private cash management services.

Managing Director, Initiative Ventures

2003 - 2007

Assisted early-stage clients to complete their financing through regional angels, venture capital firms, banks, or other lending institutions. • Worked with clients to develop corporate strategies and their business plans and presentations. • Developed the Southern MN Equity Fund that invests in business start-ups in Southern MN. Member of the Investment Committee. • Business development liaison for the University of Minnesota’s Hormel Institute. Created a partnership between the Hormel Institute and the Mayo Clinic. • Participated in several collaborations with Mayo Clinic, Mayo Medical Ventures, and Mayo Clinic’s Office of Business Development to design innovative strategies for business start-ups.